Health, biotech and agriculture
Anhui Zhifei Longcom智飞龙科马
About the company
Anhui Zhifei Longcom is the Hefei vaccine research and production base of Chongqing Zhifei Biological Products, which acquired it in 2008. With the Chinese Academy of Sciences’ Institute of Microbiology it developed a recombinant protein COVID-19 vaccine that received emergency-use approval in China in March 2021, and in 2025 it launched a quadrivalent influenza vaccine. Its plants are in the Hefei High-tech Zone.
Video
No video yet. A company video is an add-on for companies with a profile.
Presentation
No presentation yet. A company presentation is an add-on for companies with a profile.
News
No news yet. Once the company claims its profile, hefei.be follows the news on the company website and whatever the company approves appears here.
Partnerships on hefei.be
No confirmed partnerships yet. A partnership only appears once both companies confirm it.
More in this sector: Health, biotech and agriculture
Go to the full company directory: 100 companies and institutions